<SEC-DOCUMENT>0001144204-15-045561.txt : 20150731
<SEC-HEADER>0001144204-15-045561.hdr.sgml : 20150731
<ACCEPTANCE-DATETIME>20150731171922
ACCESSION NUMBER:		0001144204-15-045561
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20150731
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20150731
DATE AS OF CHANGE:		20150731

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ABEONA THERAPEUTICS INC.
		CENTRAL INDEX KEY:			0000318306
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				830221517
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15771
		FILM NUMBER:		151020210

	BUSINESS ADDRESS:	
		STREET 1:		3333 LEE PARKWAY
		STREET 2:		SUITE 600
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75219
		BUSINESS PHONE:		2149055100

	MAIL ADDRESS:	
		STREET 1:		3333 LEE PARKWAY
		STREET 2:		SUITE 600
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75219

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PLASMATECH BIOPHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20140922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ACCESS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19960209

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHEMEX PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v416855_8-k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Washington, DC 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CURRENT REPORT PURSUANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>TO SECTION 13 OR 15(D) OF THE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Date of report (Date of earliest event reported):
<B>July 31, 2015</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>ABEONA THERAPEUTICS INC.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant as specified in
its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <TD STYLE="width: 34%; text-decoration: underline; text-align: center"><font style="font-size: 10pt"><b><u>Delaware</u></b></font></td>
    <TD STYLE="width: 32%; text-decoration: underline; text-align: center"><font style="font-size: 10pt"><b><u>0-9314</u></b></font></td>
    <TD STYLE="width: 34%; text-decoration: underline; text-align: center"><font style="font-size: 10pt"><b><u>83-0221517</u></b></font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="text-align: center"><font style="font-size: 10pt">(State or other jurisdiction of incorporation)</font></td>
    <TD STYLE="text-align: center"><font style="font-size: 10pt">(Commission File Number)</font></td>
    <TD STYLE="text-align: center"><font style="font-size: 10pt">(I.R.S. Employer Identification No.)</font></td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 0; padding-left: 0; text-decoration: underline; text-align: center"><font style="font-size: 10pt"><b><u>3333 Lee Parkway, Suite 600, Dallas, TX</u> </b></font></td>
    <TD STYLE="width: 50%; padding-right: 0; padding-left: 0; text-decoration: underline; text-align: center"><font style="font-size: 10pt"><b><u>75219</u></b></font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: center"><font style="font-size: 10pt">&nbsp;(Address of principal executive offices) </font></td>
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: center"><font style="font-size: 10pt">(Zip Code)</font></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>(214) 665-9495</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Registrant&rsquo;s telephone number, including
area code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>N/A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Former name or former address, if changed
since last report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">o</FONT></TD><TD STYLE="text-align: justify">Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">o</FONT></TD><TD STYLE="text-align: justify">Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">o</FONT></TD><TD STYLE="text-align: justify">Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">o</FONT></TD><TD STYLE="text-align: justify">Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><BR>
&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 1.01. Entry into a Material Definitive
Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 31, 2015, Abeona Therapeutics Inc.
(the &ldquo;Company&rdquo;) signed a letter agreement with Sabby Healthcare Master Fund Ltd. (&ldquo;Sabby Healthcare&rdquo;) and
Sabby Volatility Warrant Master Fund, Ltd. (&ldquo;Sabby Volatility&rdquo; and, together with Sabby Healthcare, &ldquo;Sabby&rdquo;)
whereby a Purchase Agreement between the Company and Sabby dated May 6, 2015 and Warrants issued thereunder were amended as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 4.12
of the Purchase Agreement was deleted in its entirety from the Purchase Agreement and is of no further force or effect and the
Company shall be permitted to engage in Variable Rate Transactions (as defined in the Purchase Agreement) and no other agreement
between the parties shall otherwise prohibit the Company from engaging in Variable Rate Transactions; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 2(b) of each of the Warrants
was amended in its entirety to read as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<U>Exercise Price</U>. The exercise
price per share of the Common Stock under this Warrant shall be <B>$</B>8.00, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 9.01.&nbsp; Financial Statements
and Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;&#9;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>(d)&nbsp; Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company hereby
furnishes the following exhibits:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">10.1</TD><TD STYLE="text-align: justify">Letter agreement dated July 31, 2015 between the Company
and Sabby Healthcare and Sabby Volatility</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.75in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr>
    <td style="vertical-align: top">&nbsp;</td>
    <td colspan="2"><font style="font-size: 10pt">Abeona Therapeutics Inc.</font></td></tr>
<tr>
    <td style="vertical-align: top">&nbsp;</td>
    <td colspan="2"><font style="font-size: 10pt">(Registrant)</font></td></tr>
<tr>
    <td style="vertical-align: top">&nbsp;</td>
    <td colspan="2">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; width: 51%">&nbsp;</td>
    <td style="width: 3%"><font style="font-size: 10pt">By:</font></td>
    <td style="vertical-align: top; width: 46%; border-bottom: Black 1pt solid"><font style="font-size: 10pt">/s/ Stephen B. Thompson</font></td></tr>
<tr>
    <td style="vertical-align: top">&nbsp;</td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><font style="font-size: 10pt">Stephen B. Thompson</font></td></tr>
<tr>
    <td style="vertical-align: top">&nbsp;</td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><font style="font-size: 10pt">Vice President Finance</font></td></tr>
<tr>
    <td style="vertical-align: top">&nbsp;</td>
    <td>&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: July 31, 2015</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Exhibit Number</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">10.1</TD><TD STYLE="text-align: justify">Letter agreement dated July 31, 2015 between the Company
and Sabby Healthcare and Sabby Volatility</TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.75in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>v416855_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><IMG SRC="image_001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">July 31, 2015</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>VIA EMAIL</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sabby Healthcare Master Fund Ltd. &amp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sabby Volatility Warrant Master Fund, LTd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">c/o Sabby Capital, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">10 Mountainview Road, Suite 205</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Upper Saddle River, NJ 07458</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Sirs:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reference is hereby
made to (i) that certain Securities Purchase Agreement, dated May 6, 2015 (the &ldquo;Purchase Agreement&rdquo;) by and between
Abeona Pharmaceuticals, Inc., a Delaware corporation (f/k/a PlasmaTech Biopharmaceuticals, Inc.) (the &ldquo;Company&rdquo;) and
each of Sabby Healthcare Master Fund Ltd. (&ldquo;Sabby Healthcare&rdquo;) and Sabby Volatility Warrant Master Fund, Ltd. (&ldquo;Sabby
Volatility&rdquo;), and (ii) those certain Common Stock Purchase Warrants issued by the Company to each of Sabby Healthcare and
Sabby Volatility on May 6, 2015 (collectively, the &ldquo;Warrants&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For good and valuable
consideration, the receipt and sufficiency of which the parties to this Letter Agreement hereby acknowledge, the parties to this
Letter Agreement agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;That
Section 4.12 of the Purchase Agreement is hereby deleted in its entirety from the Purchase Agreement and is no further force or
effect and the Company shall be permitted to engage in Variable Rate Transactions (as defined in the Purchase Agreement) and no
other agreement between the parties shall otherwise prohibit the Company from engaging in Variable Rate Transactions; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;That
Section 2(b) of each of the Warrants is hereby amended in its entirety to read as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify">&ldquo;<U>Exercise Price</U>. The exercise
price per share of the Common Stock under this Warrant shall be <B>$</B>8.00, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as expressly set forth in this Letter Agreement, the Purchase Agreement and each of the Warrants remain in full force and effect
in accordance with their respective terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_002.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><IMG SRC="image_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company agrees to announce the terms of this Letter Agreement by filing a Current Report on Form 8-K with the Securities and Exchange
Commission by 9:00am (NY time) on August 3, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Letter Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together
shall constitute one and the same agreement. Facsimile or .pdf copies of signed signature pages shall be binding originals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the foregoing accurately
represents your agreement and understanding, please sign below where indicated and return a copy of this Letter Agreement to the
undersigned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>/s/ Jeffrey B. Davis</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Jeffrey B. Davis</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Operating Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>AGREED AND ACCEPTED:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">Sabby Healthcare Master
Fund Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By: <U>/s/ Robert Grundstein</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title: <U>Robert Grundstein, COO of IM</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated:&#9;<U>July 31, 2015</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">Sabby Volatility Warrant
Master Fund, Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By: <U>/s/ Robert Grundstein</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title: <U>Robert Grundstein, COO of IM</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated:&#9;<U>July 31, 2015</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;<IMG SRC="image_002.jpg" ALT=""></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"`!N`0P#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W>Z@M',=S
M=+'_`*,3(DDG'EG&"<]N*RX;>[N82MA>7=G&ER6,L^VX^T(<'*$L<(<\=/I6
M9J.I7&K^*H=#@74K.&%B;EGL5DM[I,#*EFZ`\C/?-=9%%'!"D,,:1Q(`J(B@
M!0.@`'05<Z2BE?=F*:J-VV7]?U_D8#:]?Z8+JYUVTAMK%&"PR0N9&<DX`Q_7
MBM;3-3MM7L$O+1F:%R0"RE3D'!ZU;9%=2KJ&4]01D&N$U:U?PYK\-_$VLW:R
M,66&#_5K_L'VYX&!T'-<LI2IZO5"G*5+5ZK\?Z^1WE%1V\OGVT4QC>,NH;9(
M,,N>Q'K4E;FX4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`'EMU>MX!\4I-J_B'6=2CN$9UMQ%E,$X&XE
ML9'HHS]`<5Z7;W<%T@,4@)*ABAX901D9'4'ZU,55B"0#CD9'2N9M/`6B6%]>
M7MHMU#<W2.AD2=LIOZE3V/OS73.I"JKRT:_'\K?B<\*<Z;M'5/\`#YZW.GKD
M?%D9U.]M+.W2\G9"?-^QWBH8\X^\I]N<\8_&IS;_`-DS:?8V6HWU[=P;B;::
M^7?(C9!=]PRVWL!BKD?AXQPL1J$HOG?<U\L,0E9<@["=N,<5QU(J;Y$].K'.
M]1<MO4UX(A!;QPAG8(H4,[98X[D]S4E9<FE7<E]>S_VQ>+#<0^6D"A`(&P/G
M4[<Y^N>OTKFM0M[<:CIEA-XGUN.XMIT@9D8`3NX9UWX&.BD9QTQ]:WC"+:7-
M^#[%2J.*V_%'<T5S,7A?4(_$LNK?\)+J#0.6*V;<QKG.!C.,#/'&>.M8T.D>
M,O#4%[?1:M)KTI&V*TER!U^_R>,#/RJ>_M5JE%[35_FA.K);P?X,[^BN4T+Q
M?YJI9^(S9Z;J\DFU+02_,P.-I(R=I.>`3S75UG.G*#M(N$XS5XA1114%A111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%5[VY
M%I9RSEHE*+D>=($7/8%NU6*BN8C/:RQ*4#,I"ETW`'L2._-)WMH)WMH0V%L8
M(-SM(\CDN?,D\PIGDJ&Q]T=JXK7?B!/#>R6NE11;8G*--*,[R.NT#MGO6_9^
M(_L]V-,UQ([*]_Y9N#^YG'JK'I]#S7-:]X"NWO)+K272:*9B_E.^TH3SP>A'
M^-<M:4W#]U\^YR5Y3</W/S[G3>%_$+:UH\ES=*D4L#%92O"XQG//3BO.]2U?
M=:OKSY`&OV\H)[(JOC_QW%6[JY_X1_0)M$BE1[ZZD+7;1-N6-<8V9]2!S]36
M'K2A/AN&R<RZL,?A$?\`&M<!-U,52A+I>_W,XZU:3@D]TFWZZ&K\6]<OH]8L
MM/MKJ:&U%N)SY3E?,9F(R2#R`%X^IH^&/B_59];CT2]GDN[:5&,;R'<T149^
M]U(.,<]\8]\&+5]#\1:38V7B.XN;*\L$\J&]AC\P21=E<=<CL:Z#P]K&A:+*
M;+P=IEWK&L3KM-Q.NP`>Y.,+^`[9/2OHITU'#^Q<-5UZ>MS.%24L1[93T?3K
MZ6.X\3Z1:OY6H6]G$-3,T:)=#3_M3ISP2N1P/[W:NF'2N;T+0=1BOSJ^NZD]
MUJ#H56"(E;>!3C(5>YXZG_Z]=)7D5'M&]['KTUO*UKA7G7C35[_5_$UCX2T.
MZE@F+"2\GA<@QKC.,@CH#N/K\HKK/%&OP^&M`N-1EVEU&V&,G[\AZ#^I]@:Y
M_P"&V@3VFGS:]J6Y]3U0^8S/U5"<CZ9^]^7I6M!*$76ETT7K_P``RKMSDJ,>
MNK]/^"5O!&L7VFZ_?^$=<N99[J)S):SRL6,J=<9/MAA]2.U>A5P?Q(T*>6UM
M_$>F934M+(DW+U:,')^NWD_0M73>&M=A\1Z#;:C#@%UQ*F?N./O+_GL1172G
M%5H]='Z_\$*#<).C+IMYK_@%3QU++!X(U:6&1XY%ARKHQ4@Y'0BI_"$CR^#]
M(DED>21K5"SN<DG'4FJOC_\`Y$35_P#KA_45RGAOPOJOB3PWI]Q?Z]>65F(5
MCM[2R.P"->`S'N3C/Y?2JA",L/>3MK^@ISE&O:*OI^IZ?17"_P#"LH!ROB+7
M0W8_:>A_*J=C=ZQX/\:V&AZAJ<NI:9J*D02S\NC^F?K@?\"'2H5",K^SE=]K
M-%^VE&W/&R?FF>C45G:]JBZ)H-[J14/]GB+JI_B;L/SQ7"Z/X3UCQ5IL&KZY
MXCU&/[6OFI;6K[%13]WVZ>U13I*4>>3LMBJE5QER15V>ET5PX^&EO'S!XBUV
M)Q_$+K_ZU5]$O]9\.^-8O#.K:@VI6MW"9;6XD&'4C)P3W^Z1R?3Z57L8R3=.
M5[:VLT3[:46N>-KZ;IGH%%8WBO6SX>\-7FI(JO+$H$:MT+L0!GVYS^%<?HW@
M_6/$.F0:IKGB;5$DND$JP6TNQ44\CVZ=@!C-*%%.'/*5EMW*G6:GR15WN>DT
M5PG_``K.)!F'Q)KB/V;[3G'Z56T+4M9\.>-T\+ZQ?OJ%K=1%[2XE^^,9.">I
M^Z1@D]L4_81DFZ<KM:[-$^WE%I3C9/3=,]$HKF_'T\UMX'U.:WFDAE5%*O&Y
M5A\Z]".17-:)X?UOQ7H5C=ZGKU[9VA@58K>U<AG4#&]V/5FY/Y4H45*'M)2L
MKV'.LU/V<8W=KGI-%<(_PRB4;K7Q)K<,PZ.;C.#]`!_.CP1K&L1Z_JGAC6[@
M7<]BHDCN3]YD..OK]Y3Z]J;HQ<7*$KV\K"5:2DHSC:_G<[NBL#QE<ZQ;>&YS
MH4$DM^[*B>6H+(">6`/M_.N>M?AU<7=I#+JWB76GN74-(J7!558CD<YZ5,*4
M7'FE*WXLJ=22ERQC?\$>@45P<GPWD@1FTWQ1K5O/@["\^Y<]L@8H\&>+[N?1
MYH=9#S7EK<O;M(H'S;0.O3GG'X53H)Q<J<KV\K$JNU)1J1M?YG>4445SG04-
M7TBTUJQ:UNTRIY5AU0^HKR#4;:_T2^ETV:YE&P@820A74\@@>GM7MU>7?$2Y
MBF\010I]^"`+(?0DDX_+^=<6-A'EY^IP8Z$>3GZG(XQ_CTJUXJ_<^`M%B_Y^
M+R:;IZ?+_6JIX!./QJ;X@G[/;>'=-).8;#SF'H9#D_\`H-:Y%#FQ:?9,\MNU
M.;\OS9Q->\?"W2[.T\'P7L*JUQ=EFFDQSPQ4+]!C]37@]=;X/\>WOA17MC`+
MNP=MYB+;61NY4^_'!_2OK<;1G5I<L-_S,\#6A2J\T]OR/H*BL3PQXFM_%&GM
M>6]K=6Z*VT^>F`Q_V2.&%7]4M)[_`$RXM+>[:TEE0H)U7<4SU(Y'.*^=<'&7
M++0^D4U*/-'4\I\27&I^//%S6NBV\=Y8Z00=LC@12-GDDYY!P0/8'UKI1??$
ML``:/H^!_P!-/_LZZ#PGX7M?"FDFR@D,SNY>69EP7/;\`/Z^M;M=53$QTA"*
M<5M?\]^IRT\-+6<I-2>]O^&Z'!&^^)3*5;1M'(/!!DZ_^/USGA:XU/P)XL6P
MUJV2TL=6.46-]T<;YPN#SQR%.3T*DU[!6#XL\+6OBS2A9SR-#(CAXIE7)0]^
M.X(_IZ44\3%WA.*47O;\]^@5,-)6G&3<EM?\MNI#X_\`^1$U?_KA_44[P'<1
M7/@?26B8$+`$;!Z,O!'YU->:!+?^$'T.YU!I)'A$379C^8X/!*YZ\>M8"_#B
M2QBA_L7Q#>Z;*(U6?RAE)F`QO*YX)[U,73=+V<I6=[[>1<E457VBC=6MOYG=
MUYWXU(N/B)X0MHL--',964=0NY3G\E;\JMCP7XF8`/XZOL8YVP`?^S5H>'_`
M]IHNHOJES>7.I:FP*_:;ELE1[#G'IG/2BG[.DW+FN[/1)]5;J*I[2JE'ELKK
M=KH[]"3X@0O/X$U=(P2PA#\>BL&/Z`US'AKP#HNL>&M/OUU+5`9H5+K%=857
M'#`#'&&!KTMT61&1U#*PP01D$5PQ^'!LKF630/$%_I,4C;C`GSH#[#(_7-.A
M6M3<.;E=[W"M1O44^7F5K6'_`/"KM'SG^TM9ZY_X^_\`ZU5K3PQX5T+QCIT)
MU/4)=8P9+>&:0R9&UAR0O`X8]15C_A#?$[<-XZO-IZ[;8`_^A5H>'O!%EH=^
M^I375SJ&I.NTW-RV2!TX';CCN<53JVB[U+Z;+_@K8A4DY+EIVUW;_P`F5/BE
M`\_@.[*`GRY(W;'IN`_K6]X:N8KSPQI<\+!D:UC''8A0"/P((_"M"XMX;NVE
MMKB-9(95*.C=&!X(KB(_AS<::[C0?$^HZ=`YW>00)%!_,?XUE"4)TO9R=FG<
MUG&<:OM(JZ:L=Y7G6OLEW\8_#\$#!I+>!FEP?NC#'!_#^8JX?!/B.08D\=:A
MM_V(=I_1JT_#/@FP\-W$UXLT]Y?S#$EU<-EL=3CZ]^IJH>SI7ES7=FMGU]29
M^TJVCRV5T]6NGH-^(O\`R(.K?]<U_P#0UJ]X0_Y$[1O^O.+_`-!%3^(='77]
M!NM+:8P+<*`9`NXKA@>GX5/I-@-*T>ST\2&46T*Q!R,;MHQG%9N:]@H=;W_`
MT4'[9SZ6M^)<KS_2?^2UZ[_UX)_**O0*P;3PREKXSOO$0NF9[J`0F#9PN-O.
M<\_<_6E1FHJ:?56_%#K0E)PMT=_P9B_$[6+_`$W2+&VTZY:VEO;D1-,K;2JX
M['MSCFF1?"ZQ,>;O6]9GF/WG%SM!/TP?YFND\1^';+Q/I1L+[>%#!XY$.&1A
MW'YD8]ZYN/P/XAMU$=OXYOUB4857AW8'89+5O2JI4E&,N5ZWTW^=F85:3=5R
ME'F6EM=OE=$O_"M;2`B2QUS6K:X7E)/M.X`^XQS7'>%!(;;4O.=9I?M\N^11
MP[87)''0]:Z__A!=9N"$O_&FIS0'AXXE\K</3()J72?A[;Z1#/##?.8Y)FE4
M&(?("``N<\X`ZUJJ\5!J4^9Z=/\`@&;HR<TXPLM>O_!.SHHHKS3T2AK.JPZ+
MI<U[-R$&%7/+L>@KA-#\(7.OROJVL.\4<[&0(HP[YYSST7TKK]0T-M5UNWGO
M&1K"U7=';_WY,_>;V`Z#ZUMUA*E[25Y[+H<\J7M9WGLME^IY'K/AR*T\70:3
M:[FBG,97<<E0Q.[/TP357QIX5\1>(?&MV]EIDAMHDCBBD<A$*A1T)//)/2NX
ML;;^TOB%J%^RYAL$6!"1_P`M"O/Y`G\ZZZM<OJ/#3E4@M]$<RPD*L9)Z)OIY
M'S'9Z)<S^)(=#N,VUP]P+=]PSL.<$\=:[CQ'\)KG3[076B3R7I09D@D4;S[K
MCK].OUK:\8Z)]F^(OAS6XD/EW5W%#,0/^6@(VD_5>/\`@->E5[-?'S7).#T:
MU1C0P%-\\)K5/1G.>#/$MIXBT9?*C6WNK8"*XM0-OE,..!_=../R[5O7,_V>
M!I?*EEQ_!$N6/T%9[>'=..O1ZU%$T-^JE7DB;:)5(QAQT;L?7@5JUY=5Q<KP
MTO\`@>G34U&TM^YCIXBBDGE@33]0:6+&]1!]W/3OWJ_>7L5C8O=S!O+0`D`9
M/)QT_&JEC;S1Z]JL[QE8I1"(V_O84Y_G1XBMI;S0+NW@1GD=0`JG!/S"L$Y<
MK?45Y*+?74TG8(C.W11DU':7,=Y9PW46[RYD61=PP<$9&16=+H2&)]M]J1.#
M@"[?TZ=:LZ-%);Z)80S(4ECMT5U/8A0"*:<KV:*3ES6:*T7B".=-\-A?RQ[B
MH=(>#@X..?4&M."7SX$E\N2/<,[)!AA]17)V%K);6HAN+36UD$CDB"?"<NQ&
M,.!TKJ+(YLXODG0;?NSG+_CR>:FG*3W(I2E+XBBFOQS;C#87\J*[)O2'()4X
M..?4&K=AJ,.HQR-$LB/$^R2.5=K(V`<$?0BLK3-&N!:/YM_?6[&>8^4CH``9
M&(_A/48/7O5K1+*:R?45F,CE[HLDTI!:1=J\G'H<@=.!1%SNKA!SNKEV_OX=
M.M3<3[RN0JJB[F=B<``=S3[2ZAO;2*Y@;=%*H93TXK'N[;5+[6UGA2&.WLLB
M$7`)$DA'+X![#Y1GU;VIVDVVH:=J-Q!.D;VMR6G5H`0L3_Q+@G/S?>^N:.=\
MVV@U.7-MH7;W58K*ZCMO(N)YI$,@6%-V%!`)//N*9!K,4UY%:R6UW;RRAC'Y
MT6T-@9(!YYQ4%[87-SX@MY8IIK>);616EB"\L63"_,#V!/3M4\.C[+Z&[N+V
MYNI(0PC$I4!21@G"J.<<47G?0+SYM.Y+J&I1:=Y`>*:5YWV1I"FXDX)_D#3;
M;4S<SK%]@O8LY^>6+"CCN<U2\16TL\VFR)#<2)%<%I#;-M<#8P&#D=R/SHTT
M*+U,6^LH2I^:ZE+1CCN-QY_"AR?/83E+GMT-2YO(K66VCDW;KB3RTP,\X)Y_
M`&B]O(K"U:YGW>6I4':,GD@#]2*I:W'.387,,#SBVN1(\<>-Q78RY&>N-PXJ
MEJ=W<:M8-90:5?(\CI\TR*JJ`X)).[T%.4VK_@.4VKK[C<NKC[-`91#+-@@;
M(ERWY5FQ^(8Y9I(4T_4#)$0)%\C[N1D9Y]*V*S-/MIHM9U>:2,K'-)&8V/\`
M$!&`?UXIRYKJS*ES75F6[V\BL+5KB;=Y:E0=HR>2`/U-27$\5K;2W$S!(HE+
MNQ[`#)JCKUO+=:/+##&9)"\9"CV=2?T%/UJTDO\`1+VTAQYLL+*F3C)(XH;:
MO8&Y:V[?YE<:Z63>-)U0IUSY`Z?3.?TK1M+J&^M(KJW??#*H9&QU!K-36I1&
M%.C:D'`P0(UQGZ[L5?TXW#:?`UW#'#<%07CC^ZA]*47=[_@*$KO>_P`BD-?C
ME9S;6-]<QJQ7S8HAL)!P<$D9Y!'%7;&^AU"W,T(<`.R,LBE65@<$$&N;6W:!
MI$DL=9@;S'8I8W!,1RQ.1\W&<YQQR36UH2WJV+B]\X'SF\D3L&D$?\(8COU_
M2IA.3E9D0G)RLS3HHHK8W"BJMU8K=NK&>YC*C&(9B@/X"J_]C)_S_:A_X%-5
M)1ZLEM]C05%3=M4#<<G`ZGUIU9O]C)_S_:A_X%-1_8R?\_VH?^!34[1[_@%Y
M=OQ-%E5L;E!P<C(Z&EK-_L9/^?[4/_`IJ/[&3_G^U#_P*:BT>_X!>78TJ*S?
M[&3_`)_M0_\``IJ/[&3_`)_M0_\``IJ+1[_@%Y=OQ-*BLW^QD_Y_M0_\"FH_
ML9/^?[4/_`IJ+1[_`(!>7;\32HK-_L9/^?[4/_`IJ/[&3_G^U#_P*:BT>_X!
M>7;\32HK-_L=?^?[4/\`P):C^QD_Y_M0_P#`IJ+1[_@%Y=OQ-*BLW^QD_P"?
M[4/_``*:C^QD_P"?[4/_``*:BT>_X!>7;\32HK-&C(/^7[4/_`EJ/['3_G^U
M#_P):BT>_P"`7EV_$TJ*S?[&3_G^U#_P*:C^QD_Y_M0_\"FHM'O^`7EV_$TJ
M*S?['3_G^U#_`,"6H_L=?^?_`%#_`,"6HM'O^`7EV_$TJ*S?[&3_`)_M0_\`
M`IJ/[&3_`)_M0_\``IJ+1[_@%Y=OQ-*BLW^QD_Y_M0_\"FH_L9/^?[4/_`IJ
M+1[_`(!>7;\32HK-_L9/^?[4/_`IJ/[&3_G^U#_P*:BT>_X!>7;\32HK-_L9
M/^?[4/\`P*:C^QD_Y_M0_P#`IJ+1[_@%Y=OQ-*BLW^QU_P"?[4/_``):E_LA
M/^?V_P#_``):E:/?\`O+L:-%%%248VI32V6O:3.)7%M<,]I*FX[=S+N1L>N4
M*Y_VJP]*UJ>TN[G4[^XF>QU"VFO((W;Y8EB;`"CMNC*-]<UU&K:7!K.FR65P
MTJ(Y!#Q-M=&!!!4]B"*JZAX;T_4;&RLI5D2"S93$L;8^4#;L/'*D<$5T0G#E
MM+^D<\X3YKQ]5Z[%*TO=1T_2='LW07.J7H9G-Q*55#@R,"<$X&=H&/3I4C>(
MYET>>Z^Q*;J"\6R:$3?*7,BID-CI\P/3-:6H:8FH-;R>?-!/;N7BEA(RN05(
MP0000>XJ!-`M4T\VC23.&N1=/*S#>\@</DX&.H`P!T%+FIO5K4?+46B>G_`_
MX<S-9U>[L=.M;K4E%@(=019FBD++)'@G(P`<'I@CM5VXU*86>FSW5H\+W%Y&
MBQ)/@H&)VEB.#QU7D9.,G&:T;VPAOQ`)MV(95E4`]2,\'VYJI'H%I%:6]JLD
M_D6UP+B!"X/EXZ(./N#)X].,XH4H-*ZU!PFF[/0HWOB*]MGU26/3X7L]-D5)
M7:XVNX**QVKM(R`W<C-7;S4[M-5-A8VD4SQP"XD:68QC:6(`&%.2=IZX%23Z
M):SV^I0NTNW43NF(;D'8J?+Z<**Y_P`7W\&D:G!=RF[B^T0&W\RTD4.^&R%8
M,I``W'Y@<C)IP4)M1BM?^&_X(IN<%S2>G_!?EZ'3:1?G5-'L[\Q>4;F%)?+W
M9V[AG&>]4-*OM4NM7U2&>.V^R6]UY2,KG>!Y:,!C;@_>SG/>K>A6CV&@:?:2
M%2\-O'&Q4DC(4`XS3$T.!-7;45GN`S2&8P[QY?F%!'NQC.=HQC..^,U'N)R7
MW?>7[[47]_W%"S\1W5P-/N9;&*.POYC#"PF)D4X8J67;C!V]CQD>]-O/$EY#
M'>W4&GQ2V=I<BV9FG*R,VY5+!=I&`6]<\&K=MX;M[:6UVW5T]O:R-+!;.R^6
MC$$=ADXW'`).*Y/6I(I/$-SX?C>YAGN[J*X5$=3`W*$LV5W!OE/R@X)`/<UM
M"-.<O=6GZ7_R,9RJ0CJ_^'M_F=%JWB<V&HW%G!%;.]M"LKB><QE]V["IA3D_
M+WQU%.EU74YM:TV*R@@^S75B]PR7#LC@AH^N%."`_3W/3'-V\T1+J[FNHKZ\
MM)9HEBE-NZC>!G!Y4X(W'D8--O\`P_;7ZP*T]U%Y4+6^Z.3YGB;;N5B03SL7
MD8/O6:=*R-'&K=ZF;<:KJ-CJVNRPP+<VMI%%,R23E2!L)8(,$9.,\X%6M6\1
MBQO+:UA6W$DT#3[[J4Q(%!4`9"L<G/X8J]-H]M-_:.YI!_:$8BFPW0;2OR\<
M'!IMSHT<]Q;W$5U<6MQ!$81)#MRR'!P0RD'E0>G\Z%*FVKK^K?Y@XU$G9_U?
M_(IG7[B?3-+N+2Q4SZA(8Q'-(5$9".Q)."2/D].<UJV$UQ<64<EU;?9ISD/%
MNW8()'![@XR/8U#'I,*16"&:XD-DYD1Y)"S.Q5E)8GK]XU?J)N.T47!2WDS%
MTJ]U2YU34HKB*V^RP71B1ED.\#RT8#&W!^]G.>_M4%GXANK@Z=<2V,<=CJ$A
MCA83$R*=K,I9=H'(4]"<9'6KR:)!'J[:BL]QN9S*8=_[O>4"%L8SG:`,9QWQ
MFH+7PW;6LMKBZNGM[21I+>V=EV1L01QA<G`8@9)Q5WIO^O+_`#(M4T_KK_D6
MM>GN+;P_J$]J5$\=N[H2<8(4G/0\UGV4LEH-"M9TD,LXD^87;N.$+9;</FSZ
M'H>G2MJ\MDO;*>TE+".>-HV*GG##!Q^=0OIL#SV,Q+[K+=Y7/!RNTY]>*B,H
MJ-G_`%H5*,G*Z_K4R5\0WI;SFT^%;+[>;'?]H)D)\WRPX7;C&>V<U#X@UG4/
ML>NPZ=;)ML;5O,G,Y1PQC+#8`IZ`@\D5K#0[46WV?=+L^V?;/O<^9YOF?EN_
M2H-0\.6^H/>$W=Y`E[&([F.!U`D`!7/()!P<<$9P,UI&5+F3M_5U_P`$B4:O
M*U?^K/\`X!JVY)MHBQ+-L&2>_%<ZWBLQZLEJT5J8WN_LH"7.Z0'.`V-NWW(W
M9`/KQ72(@CC5%Z*`!6./#4"R1[;R\%O'<_:DMPZ[`Y<N?X=Q&XDX)J(.&O,7
M-3LN4U;F=+6UFN),^7$C.V.N`,FL[2]1U*\-M)<:='%;7,/FI)'/O,?"D*X*
MCD@GID<&M26-)HGBD4,CJ593W!ZBLRPT**PEMW^V7<XMHC%`DSC;&IP.P&3A
M0,MFICR\KON5)2YE;8BM-?\`M5CI5S]GV?;[AH=N_.S`<YSCG[GZTV+6-0N-
M3GA@TZ-[2WNQ:RR"?Y^55MX7&,#<,\YI\'ANWM[BV=+N[,-K,TT-N7'EHS!@
M>V2/G.,DXJ_:6$-E)=/$7)N9C.^XYPVU5X]L**MNFKV7]7_R(BJCM=_U;_,P
M?^$M)U!XDMX&A2\^R%1,3-D/L+A-N,`\]>@S745DC0(UN'>._OHX'N/M#6Z2
M`(7SN/.-V">2,X.3VJS/I[33O(+^\C#8^2-P%'&..*4_9NW+H.'M%?FU/__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"``X`ND#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#WXG`)]*Y5
M/%%RMC#=-)I\YE@>7R(')DC(C+Y89/'&T].2/I75D9!%9Z:/;QZ,=-3Y5-M]
MG,H4!B-N,_7O6D'%?$B9)O88-<ML$&*Y$P95$)A.]MP)&!Z85C_P$TU_$-@D
M>\^?A5WR8A;]TH8J2W'&"I!^E.N=&6:]^V1W,D5P"A1@H8*5#KT/7(D8?E42
M^'X1:W<)N)6-U"T4CX`.69V+#C@YD/Z4U[,7OE@ZQ;"9X@D[;2ZAEB)5W4$L
MJGN>#^1J>\OX+&U,\[[5`R`>"?SJA'H$<-[+<P3"-V:213Y*%E=\Y.XC)&23
MC^G%:KQK)$8Y/F5AAO>I?)=6&N;J9]_J4T"VTEI%'-"\J+)*7X56<)QCJ>?I
MP:LW\US#;AK6.-G+`%I&PJ+W8^PI]W:K>0B)F*@2))D>JL&Q^E0:KIHU2V2%
MI3&$E63[H8-CL0>"/\!0G'0'?4IV^K7<]K>".&"XN+>41*\3XB;*ALDGH!GD
M#)X]ZG&JL=*LIUC#W=Y&ABA!X+%03]%'4GT]ZL6=G);6K023+(#G;MB"!1Z`
M"H?[$LF@M(Y8VD:UB$,<F\JP7`SRI'7:/RIMPN*TBLVMR1>&+?5)(XQ+*(@5
MW$(K.RKG/7`W9]>*J/XEEBMR2]I(YG2%74.H3<"<LA&[^$XQUS[5=B\/Q0:7
M#IT5S,D$*H8^02'1@P?)Z\@<=/:E?0VF=IYKZ1KK=&R2B-1LV;L#&.?OOG/K
M5ITQ-3*C:[>-;1M`+>5VNC"SI%(VU1&6Y0#<#D`8/KGO5DZRT>A2WQ>&66-_
M+;Y6B5&WA?F#<KC.3GM4BZ/*GF2IJ,RW<DHD>954!L+M"E>A&/UYI8M(>*WE
MC6_G#S,TDD@5<M(2I!Z8P`N-O0@G.:3<`M(KV^N[)+J.[DMYC#&DBO9DL'W$
MJ$Q_>R!@9YS4(UZ[$`$T5K;S->-;;I')CC`7=\Q[GMV&:LP^'+;>TEXWVASM
MVD((@FW)&`F.?F/-">'8;>&:.TN)8?-G\YMV)%/&-I#9!'?USCFG>F*TRF?$
M%XYCCA2WD99WBEFA1YD.U%8;0O/.['L0:V].N3=V,<Q='8Y5BB,HW`D$8;D8
M(Q@U2BT22WB'V?49XIC(9'=47:Q*A<%,8P`HQZ5=L+);"V\H2-*S.TCNV`69
MB23QP.34S<+>Z5%2OJ,9W_MN./<VPVS,5SQG<O.*=JEVUCI-Y=HJL\$+R*K'
M@D`GFHV_Y&"/_KU;_P!#6I[ZU6^L+BT9V19HVC++U&1C-3I=7'K9V,RUUM?*
M:2XNK:Y!=8T6R1F.XYX/)]/YU8AUZRFD"`3KD/@O"P!9,[E''+#!X]N*5=,G
MD,1N[]Y_*E65/W:I@@$8X]<_I4<N@P31"-II@H>=\J0#^]W9Y]MQQ5?NV+WA
MDWB"#R'>(%)4_P"6<R%2V49EQ]=A_(U;AO\`S=*:[93'LBWL64[?NALCN1S^
ME4%\,0_,S3G>VW)CB2,<*ZCA1U_>'\A6BM@!ITED\SM&T?E*<#*KMVX''X\^
MM$N3H"YNI7&O6FY4_>NQ(3<D3;2Y7<%!/<@\?7%5K/Q&CZ;!<W<,JR20_:'2
M.%CY49S@M[<'GO@D"K4>B0I%&GFR'9<)<9XY*J%`^G%0OX>7[-'!%>31K]D6
MTE(529(USCJ.#R>1ZT_W>PO?%DUY4F(2W9X@VWS`WL3Z8Z`D<^E%_P"((+2&
M[V1R>=#%*\8D0JLC(I)`/X?X5(="M_.#!F$88-Y?;C/^)'/8U5?PM;222EYY
M-KB8#:BAAYH(;+8R<;CC/MUH7L^H/G+G]MVPRIBN5FW*HA,)#MD$@@>F%;\C
M37U^R10V)V4(9)"L+'RE!*DOZ<JW_?)J"?PZEVYFN;II[@,I1Y(D*@*&`!7&
M#]]OQQZ4K>'E\EHH[R2))8?(G"1H`Z98\#&%^^W3U]J+4P]\LC6[,W!A_??>
M=`_DMM9D!+*#CD@*3QZ&JTGB2W5X42UNY)))5C,:Q?,H*LP;'H=C#\#4LN@P
M36P@,TJIYLLOR$`_O%=2`?;><?0577PTB9D2[:*?*%7AA1`NT.!\H&,XD;GZ
M>E"]GU!\Y-!KT+3S17*-"$GDB64J=AVC/7UP"?PIXUZS\O<5G4G9M0PMN</D
M*0/?!_KBA]"@D@\EI92IG>9N1EBRLI&?3#&H;7P[#;!,2CY'C<;(43.S.,X'
M)YZ_RI?NP]\L+KEHSPKMG"RE0':%@H+'`!SWSQ]33(_$-A)$9<S+'Y9D1FA8
M"100#MXYY(&/<4VXT&*XU$W9F(W2QS%3&I(9"N`&(R!\HX'J?6J5GX::72HH
M-1G<LL!B6-0N(LLK'G'S<JO7TII4[7"\[FM!JUM/.EOB5)W9E\MXR""H#'/X
M,#^-44\2P3K=-'%+''"B.)Y8SL8,`1TY[]*DCT$0^5)#<^5/'(SAHX45?F`!
M&T#'8<]?Y5$OAB)+<VZ7MP(&A2)D^7+%5"AB<>@Z=,\T+V8>^6GUVRC\QF\X
M1H6'F^4Q1B#@@'')SQ_*IQJ<`LY;J99H(XN'$L9!'T'?J.F:JG1'*RQ"_G6W
M8NRQ!4P"Y).<CYADG@^M1Q^'8TM)[;[2RQSG<ZQ1JB@X7:5`&%QMS[DG-*U/
MN.\BR=:MU1<Q7(F9S&(/).\D#)X],'.>GXU$WB/3U7?NF:,*K,ZPL0@8D#/'
M7((QZTK:1,Y29]1F-W&Y9)2BX4%=I4+C&,<_7\J8GAVW2TEMQ-*5E$88G&<H
MY?/3N2:/W?4/?+]G>Q7J2-&LBM&^QTD0JRM@'!!]B#^-6&^Z?I4%O:+;S74B
MLS&XE$C`]CM5<#_OG]:G?[C?2LW:^A2O;4K::[2:59N[%F:!"68Y).T<FJNM
MZI-IL<(MH5FF<EBAS_JT&YSQWQP/<BK.E?\`('LO^O>/_P!!%17.CV]YJ'VN
M=YBRQ>4BI*R!03EOND$YPN<_W15+E4O>$[\NA7;7X8[V9'1S;)#%*)XT+*`^
M[DGL.!4QURR5Y`[2)&@D/FM&=C;,[]I[XP?RXS51?#,<<+6\=[<+`\20.A"G
M=&I;:,D9SAL9]!Z\TO\`PC%KNN`7_=3"086)`PWY)^?&3C)Q_6KM2)]\L_VY
M;#Y&BNEFW!1"86WMD,00/3"MS[&D;7[)(8YCYWE,NYG\HXC&2OS>F""#Z8YI
M8='*WJ7D]W)/<*RG<551@*Z@8`_Z:,<U2F\*6TJLAG?:ZE6W(K$`NS_*2/E.
M6/3T'I22I]0]\NZY=WUA9?:;,6[!"`ZS!N<D`8Q]:@CUJ2VNY;7444&,1[IH
M$8H"Y(&<].<5HW]DFH63VLC,J.5)*XSP0>_TJ"XTF*Y:Z+2.IN?*W;<<;#D8
M^M*+C:S&U*]T,.O6"^87:18T5V$AC.UPG#;?7'_ZLTDFO6L41DDBN5"[C)NA
M8>6%QDG\#GC/%5E\+VJ"X1)-D<JNORQ(&&\Y.6QD\D_US4^JZ##JLK/)*5WP
MF!@8U<;3GD9'RGGK3M3N+W[$HUNR^TM"6D`5VC,IC.S>!N*[O7&321Z[92;.
M94+L@0/&1O#G"L/8XJE;:#(\]P;N9_LYNGEC@!&#E-H.[KT).,]?RIT/AF&W
MM_+CGV,IC,;I"BE2AR"<#YCZY_2FU3[A>9.-?@?5#91P3MA7+3!/D4JVTY_'
MO3[?6;>80K^\D+JFZ6.%O+#,H(&3TR&'7ID9J&+P^(I5E6^GWDN93A1YFYMY
M'3@9].W'O3K70S9%$@OIT@_=EXP%R[(JKG.,@$*N0/ZTG[.V@USEJQU.#4!F
M%)@A4.CO$55U/0@]/ZU43Q!`D+-<)('5IB5B1GQ''(4+''T%/T[1(]/O&N1-
MO8Q^7Q&J;AG.6V@;FXZ_7UI1H<($X\Z7]['-&3QP)'+DCZ$T?N[^0>]8FCU:
MUEN1!'YCY;9YBQDINQG;N]<?AVZTNI3W5O"KVX@51DRRSGY(U`]!R:K1:*]N
MS"WU">*(G?L"K]_;MR3CD<`X]?;BK5W92W'DO%>2P319`=0"&!'.Y>AZ?A2]
MU/0>MM3-CUB\GTU+M?L4,0:027,CDQD*VU2HX/S=?;&.>M-;6[QM*@OR+.T@
M:+<TMPS%6;)`"@8('`.3ZCC@U9CT62W"M;ZC/'.6=I'VJ1(7()^7&!R.,?K1
M%HLMK&BV>I3PD)M<LJN&.YFW8(P#ECT]O2KO3)M(JWNN7MOIZ7YCM;>%H%D5
M)W.Z1RNXHN.A'3D5IW%\\-SIT0B'^ER,C9/*8C9_SRH%4V\/E+4VEOJ%Q%:M
M"L#QD*^5"[>"1P2/UYJS>Z6;A;+R+E[>2S?=&P4-GY"F"#[-4OD'[P^XU:UM
M;DP2%R5VF1E0E8]QPNX]LFB#5K:XNA`GF98L$=D(5RIPP![XJFWAY9;M;J:Y
M$DY"^9(T"$MM)(QD';UQQ_/FI+'0(+"]^T1,N`795\I`WS')R^-QZG']:+4[
M;ZA>5RE?>()[6XU';-IX6S<*()'(EE^16P.>IW8''6M%]<LXI9$F\V/8'.YX
MR`VP9;'K@`_7'&:L06$,%S<SX#R3RB0E@,KA57`/I\N?Q-9;^%[=Y)&,[C=Y
MV"$7<#(&#9;&3C<<9]NM.]-[BM)$W_"00?;TA97CC,;$^9&P??N0*`N.<[\_
MY-2G7]/!`,C@F&2?F,\*APV??(/'?!I;[1HKV[@NC*\<]O&R0NF,H20=PS],
M$="":K/X:@>25S<2YDN5N"`!@`9W(./NL68G_>-)>S>X>^6'UZRBD991-&!N
MPSQ$`[?O8^G7Z`FKL%S%<-,L1)\F3RWXQ\V`?QZUD?\`"-V\<[W!+S`>:1$%
M4,_F`[@7X)ZX&35C0["[L+&*.YF#L8PT@P"?-+,S$GOU`_"B2A:\1IROJ4;?
MQ%*\^96LE4.XDMC(5GC5<Y.#]X\#@#O[5I3ZQ;H%V-EF6*0`H?F61MJ@>YP?
MZU`^A-/LCN=0N)[:-RZ1L%W`X(&7QDXR?TI(O#ZJ5,MY-*5$*+E5`"Q.64<#
MOGG^E-^S8ESC[;7X;BPM;DVMVCW*;TA\HER,`DX'8;AS1JFM)9Z=:W4!1DNI
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M$:#.YMQ7=C.,G'KBI7)=C?-86]U^&W@NO*C<S11R-&)$*K(4Z@'_`#GJ,THU
MV**!Y+F*0!99E)C0L`D;E=Q_`9QUZXJN_A6WD:4M</AUF4$1KN_>9SEL9;&>
M,_K3KKPS!<JP\]AO\T-NC5^)'+G&1P02<'TI_NA>^7X=5MY[HP1+,X#E#*L1
M*;@,XSV^O2F:U<WEEIDUW9B`F"-Y76;=R%4G`QT/%5F\/*+M+F.X(DB^:,^4
MH8';M`+`9*^WT[5H7-H;S2Y;*>4DS0F)Y%&#R,$@5/N)IK8?O-.YFW>L7.CQ
M12ZHD+Q2`J'M@?\`6_P)@G^+H#Z_6M$&_?3XSBWCO"%+J<LBGN!T)^M1W.DV
M][<B2ZS-&L+1+"P^4;N&;UR1Q[#/K4@LY5THV8O)O,\LQBY./,'8'TW`=_7F
MAN-E;<$G<QVUK4EM6D6.WD!NQ;QRQQR,K`*=S;1DD;@5'YU834[V:W7RFM=P
MD99I94>-8L`$*58AMQW#VJ])IP6Q@M;.>2T$&/+,6#P!C!!ZCG^O6L^7PYYK
MI,]X9)Q*TKM)"C*S%54?+C`P%`'X^M5>#%:0V37;O^P#?P6T4KHT@=P_[K:C
M$%@>ISCCZ]<#-3ZAJLT&HM:12V4&R%9=UVY4/N+#"_3;R>>HJU)IYGTA["><
MMO0H9%0+Q[`<"F7VF2W=P)8[QHL*%V&))`.O(W#@\_H/2DG"XVI%FPNA?:=;
M7838)XED"YSC(SC/XU8J&TMH[*S@M8L^7#&L:Y.3@#`S4U9NU]"EMJ07-R;?
M;BWGFW?\\E!Q]<D57_M)_P#H'7O_`'PO_P`55^BA-=@LRA_:3_\`0.O?^^%_
M^*H_M-_^@=>_]\+_`/%5?HIW78+/N4/[3?\`Z!U[_P!\+_\`%4?VF_\`T#KW
M_OA?_BJOT4778+/N4/[3?_H'7O\`WPO_`,51_:;_`/0.O?\`OA?_`(JK]%%U
MV"S[E#^TW_Z!U[_WPO\`\51_:;_]`Z]_[X7_`.*J_11==@L^Y0_M-_\`H'7O
M_?"__%4?VF__`$#KW_OA?_BJOT4778+/N4/[3?\`Z!U[_P!\+_\`%4?VF_\`
MT#KW_OA?_BJOT4778+/N4/[3?_H'7O\`WPO_`,51_:;_`/0.O?\`OA?_`(JK
M]%%UV"S[E#^TW_Z!U[_WPO\`\51_:;_]`Z]_[X7_`.*J_11==@L^YC&[F.JI
M<?V?>B,0,A^1>I8'^][5:_M)\?\`(.O?^^%_^*J_10Y)]!6?<H?VDW_0.O?^
M^%_QH_M-_P#H'7O_`'PO_P`55^BBZ[#L^Y0_M-_^@=>_]\+_`/%4?VF__0.O
M?^^%_P#BJOT4778+/N4/[3?_`*!U[_WPO_Q5']IO_P!`Z]_[X7_XJK]%%UV"
MS[E#^TW_`.@=>_\`?"__`!5']IO_`-`Z]_[X7_XJK]%%UV"S[E#^TW_Z!U[_
M`-\+_P#%4?VD_P#T#KW_`+X7_P"*J_11==@L^Y0_M-_^@=>_]\+_`/%4?VF_
M_0.O?^^%_P#BJOT4778+/N4/[3?_`*!U[_WPO_Q5']IO_P!`Z]_[X7_XJK]%
M%UV"S[E#^TW_`.@=>_\`?"__`!5']I-_T#KW_OA?\:OT4778+/N4/[3?_H'7
MO_?"_P#Q5']IO_T#KW_OA?\`XJK]%%UV"S[E#^TG_P"@=>_]\+_\51_:;_\`
M0.O?^^%_^*J_11==@L^Y0_M-_P#H'7O_`'PO_P`51_:;_P#0.O?^^%_^*J_1
M1==@L^Y0_M-_^@=>_P#?"_\`Q5(=2<@C^SKWG_87_P"*K0HHNNP6?<R;"\EM
M]/MH'TZ\#QQ(C81<`@8/\53_`-IO_P!`Z]_[X7_XJK]%#DGK8+/N4/[3?_H'
M7O\`WPO_`,51_:3Y_P"0=>_]\+_\55^BBZ[!9]RA_:;_`/0.O?\`OA?_`(JC
M^TW_`.@=>_\`?"__`!57Z*+KL%GW*']IO_T#KW_OA?\`XJC^TW_Z!U[_`-\+
M_P#%5?HHNNP6?<H?VF__`$#KW_OA?_BJ/[3?_H'7O_?"_P#Q57Z*+KL%GW*'
M]IO_`-`Z]_[X7_XJC^TW_P"@=>_]\+_\55^BBZ[!9]RA_:3_`/0.O?\`OA?_
M`(JC^TW_`.@=>_\`?"__`!57Z*+KL%GW*']IO_T#KW_OA?\`XJC^TW_Z!U[_
M`-\+_P#%5?HHNNP6?<H?VF__`$#KW_OA?_BJ/[3?_H'7O_?"_P#Q57Z*+KL%
MGW*']IO_`-`Z]_[X7_XJC^TW_P"@=>_]\+_\55^BBZ[!9]RA_:3_`/0.O?\`
MOA?_`(JC^TG_`.@=>_\`?"__`!57Z*+KL%GW*']I/_T#KW_OA?\`XJC^TW_Z
M!U[_`-\+_P#%5?HHNNP6?<H?VF__`$#KW_OA?_BJ/[3?_H'7O_?"_P#Q57Z*
M+KL%GW*']IO_`-`Z]_[X7_XJC^TW_P"@=>_]\+_\55^BBZ[!9]RA_:;_`/0.
MO?\`OA?_`(JC^TW_`.@=>_\`?"__`!57Z*+KL%GW*']IO_T#KW_OA?\`XJC^
MTW_Z!U[_`-\+_P#%5?HHNNP6?<H?VF__`$#KW_OA?_BJ/[3?_H'7O_?"_P#Q
M57Z*+KL%GW*']IO_`-`Z]_[X7_XJC^TF_P"@=>_]\+_C5^BBZ[!9]RA_:;_]
M`Z]_[X7_`.*H_M-_^@=>_P#?"_\`Q57Z*+KL%GW*']IO_P!`Z]_[X7_XJC^T
MGSC^SKW_`+X7_P"*J_11==@L^Y0_M-_^@=>_]\+_`/%4?VF__0.O?^^%_P#B
MJOT4778+/N4/[2?_`*!U[_WPO_Q5']I/_P!`Z]_[X7_XJK]%%UV"S[E#^TG_
M`.@=>_\`?"__`!5']IO_`-`Z]_[X7_XJK]%%UV"S[E#^TW_Z!U[_`-\+_P#%
M4?VDV?\`D'7O_?"_XU?HHNNP6?<K6]V;ARIM;B'`SF50!].":LT44F-!1112
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`R,X[TFX8)R..OM63KI%L;#46(5;6X'F,>@C<%#^I!_"N
M>"O';R6[%EEUR..3KCYFD._'TC8?E64JG*[6_K_A]#*=7E=K?U_P^AV^1SST
MZT9''(YZ>]<SK.;+4)X8\(NIVZ0(!_?#[#C_`("^?^`TS3$5M3M=*!PFER3N
M4//&<19_X"[?]\T>T][EM_7_``PO:^]RV_K_`(;4ZG<,`Y&#TI<C..]<3<6[
MW"3Z&GWK.2XN44=0,;HOPS)C_@/M6QI%Y!>7-[J[2HL,AC@B9FP```2`3_MN
M1]11&K=VM_74(U;NUOZZFZ6`QD@9Z9JM=7HM9[2(H6-S*8P0?N_*6R?^^:PK
MP076NWRO:V,IA1$<WLO8KGY!@[1SR>Y^E4UDBN/#_AAKV0-&UPH9G?@_(X`)
M[]OK2=7=?UND)U=TOZU2.R!!&0<B@,"2`02.OM7*7&RU?7TTD*D26*MM@^ZL
MN'Y`'`.T#IZ"FVUO'%=:7+$=+M\R@*]L[,\RE3E3\O.1SD^E'M7>UOZO8?M=
M;6_J]CK=P!`R,GH*4D`9/`KD3'IDUEK4^H"!KI)YQOD(WH!]P`GD<8QBK/V<
M7VI:+'?H9";!WD23HS?N\[AWZGK3]H_Z];#55OI_5['2T@92,@@CU!KE-T-I
MH6NPE'%K%>&)(TD*!5;9P&_A7+$GVS2VL:1>)+.'R=/C$UO,)4M&RKK\N`RX
M'J<'W-'M=A>UVT_K5?H=';7MO>6HN+>021$$@CC./8_2DT^]74-/M[M5*":-
M9`A/(!%<_P"&#IL&FVD<<,(O)(I<M&@W!5;D,1TZCK56VLK:V\-Z%>0PHERT
MUMF<#YR&8`@GK@@D8]ZE5'9/R_R$JKLGY?Y'9%@,9(&>F:6N4N(S<^(=36:+
M3YO+\L(+UC\J;,_*,'C.[GU^E-AMX[B#PY;S2I<PM)*"5+;'4(^!SR0,#KUQ
M3]KKM_5[#]J^W]7L=9D8SD8ZYH!!&0<BN=U2SM=.L;:S1-\4][F..:79$A(+
M;3@?<R.%]<54@S#-KL$:6L8%@KF.U?,>_#C/3Y3@#\A3=1IV:!U;.S7]:G6Y
M!.,C([4%@"`2`3T]ZY""/3X[3P_-8F'[8\D09T;]XZE#O#=SQUS2M#]JU/5O
MM$.FR,D^W_3'(=$V+C''`Y)R/4TO:OM_5KA[7R_JUSK\C..]075Y;V<!FN)`
MD894)QGDD`#CW(KG[>0177AN2>Y5U^QRKYQ)"N=J8/S8.2!GGFJ-_P#9KJRU
MR1C'+$NI0$,<$#B(']"1^)H=733^M+BE5TNOZTN=A+*ZJAAB\W+A6PP&T9Y/
M/IZ5(6`QD@9Z9KG;Y[+[-;Q:>D<<<6J0(_DJ%4MN4G&.O!%+Y6GW.O:LNIB!
M_+$0B$Y'RQE,DC/3YMW(I\^MOZZE>TUM_77_`".A)"C)(`]32URDT=M<C2?(
ME@N$%JWE0:EN`D7Y?GS@@L..HZ'-:&AW-K%%>1[(;81W.PA)MT19E7&PG&,Y
M^[ZTU4N[`JEW8VB0,9(&>!2D@#)X%<\T5E=>(M234U@<)'%Y*SX.$(.2H/3G
M.2*KO]BG_L"%Y&ETUUDVBZ/^L(7Y-V>O&<9]C2]I_7SL'M/Z^=CJ001D<BDR
M"2,\CK7'WH@BL?$T5EM6U2&,J(3\JR%3NQC@'&WI5V_TFPAU72(X[=46621)
M=I(\U=C-A^[<@'FCVC[?U>PO:OM_5['1@@C(.12UB:/%':ZWJ]K;H(X$,++&
MO"J2IS@=LXK;JXNZN:1ES*X4445104444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`#)(HYHVCE19$8896&0?J*0V\):-C%&6B_U9*C*<8X]***+!85X8I71Y(D
M=HSE"R@E3ZCTH6&))7E6-%D?&]PH!;'3)[T446"P"&)9FF$2"5AAG"C<1Z$T
MQ;6W6$0K!$(@=P0(-H.<YQ]>:**5D*R":SMKAU>:WAD=?NLZ`D?3-.-O"T8C
M,,90=%*C`_#\31119!9!#!#;1^7!%'$F<[44*,_04R*QM()3+%:PQR'^)(P#
M^=%%%D%D$EE:33":2VA>4=':,%A^-2F-#(LA13(H(#8Y`/49_`4446060@AB
M`<")`)#EQM'S'W]:9#9VMN<P6T,1_P!A`O\`*BBBR"R%CM;>*5Y(X(DDD^^R
MH`6^I[TOV>$1)%Y4?EIC:FT87'3`[8HHHL@LAD]E:W3*UQ;0S%>ADC#8_.I/
M*C^3]VO[O[G'W>,<>G%%%%D%D$L4<\9CEC21#U5U!!_"JTVGP_8+BWMH883+
M$T8*H`!D'T[<T44-)@TF%EI\%G%$1#%]H6-4>54`9L`#KUJ6:QM+EP\]K!*P
MZ,\88C\Z**.56M8.56M8=-;07$?ESPQRQ_W74,/R-`MH%B:(0QB-AAD"#!&,
M=/I1119!9"):V\<2Q)!$L:$,J!``I'.0/6B>SMKD@SV\,I7@&1`V/SHHHL@L
MA9K6WN8PD\$4J#HKH&`_.A;6W2%8E@B6)2&"!``"#D''KGFBBBR"R$GM+:Y*
MFXMXI2O3S$#8_.G2V\,\7E30QR1_W'4$?D:**+(+(1;6W2`P)!$L)SF,(`IS
M[4]HXW9&9%+(<J2.5.,<>G%%%%D.R`1HKLZHH=L;F`Y..F:=113`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
+`"BBB@`HHHH`_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
